About
Inhalable Liposomal Therapeutics
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & FormulationNJ, NY, PA
Team (7)
Eugene Sullivan, M.D.
Chief Product Strategy Officer
Insmed
team_member
Martina Flammer, M.D., MBA
Chief Medical Officer
Insmed
executive
Michael Smith, J.D.
Chief Legal Officer
Insmed
team_member
Nicole Schaeffer
Chief People Strategy Officer
Insmed
team_member
Roger Adsett
Chief Operating Officer
Insmed
executive
Sara M. Bonstein
Chief Financial Officer
Insmed
executive
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
283
By Phase
NA: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT01898390Collaborator
TRANSEURO Open Label Transplant Study in Parkinson's Disease
NACompleted
13 participants
Started: May 31, 2012 · Completed: Dec 31, 2022
NCT00801307Collaborator
Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease
PHASE1/PHASE2Completed
30 participants
Started: Jun 30, 2008 · Completed: Mar 31, 2010
NCT00283972Lead Sponsor
LAP-BAND Observational Cohort
N/AUnknown
240 participants
Started: Jun 30, 2005 · Completed: Dec 31, 2006
Locations (1)
Headquarters
Bridgewater, NJ, United States
Map
Loading map...